Article
Targeted Nasal Vaccination Provides Antibody-Independent Protection Against Staphylococcus aureus
22 Nov 2013
Abstract excerpt
Despite showing promise in preclinical models, anti-Staphylococcus aureus vaccines have failed in clinical trials. To date, approaches have focused on neutralizing/opsonizing antibodies; however, vaccines exclusively inducing cellular immunity have not been studied to formally test whether a cellular-only response can protect against infection. We demonstrate that nasal vaccination with targeted nanoparticles...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
